BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002;11:235-256. [PMID: 12424848 DOI: 10.1016/s1055-3207(02)00002-9] [Cited by in Crossref: 271] [Cited by in F6Publishing: 129] [Article Influence: 14.3] [Reference Citation Analysis]
Number Citing Articles
1 Raman R, Deorah S, McDowell BD, Abu Hejleh T, Lynch CF, Gupta A. Changing incidence of esophageal cancer among white women: analysis of SEER data (1992-2010). Contemp Oncol (Pozn) 2015;19:338-40. [PMID: 26557784 DOI: 10.5114/wo.2015.54390] [Reference Citation Analysis]
2 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12(3): 354-362 [PMID: 16489633 DOI: 10.3748/wjg.v12.i3.354] [Cited by in CrossRef: 1071] [Cited by in F6Publishing: 975] [Article Influence: 66.9] [Reference Citation Analysis]
3 Nelson KS, Brearley AM, Haines SJ. Evidence-based assessment of well-established interventions: the parachute and the epidural hematoma. Neurosurgery 2014;75:552-9; discussion 559. [PMID: 25050576 DOI: 10.1227/NEU.0000000000000504] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
4 Melhado RE, Alderson D, Tucker O. The changing face of esophageal cancer. Cancers (Basel). 2010;2:1379-1404. [PMID: 24281163 DOI: 10.3390/cancers2031379] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 3.3] [Reference Citation Analysis]
5 Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol. 2010;105:493-498. [PMID: 20203636 DOI: 10.1038/ajg.2009.728] [Cited by in Crossref: 191] [Cited by in F6Publishing: 183] [Article Influence: 15.9] [Reference Citation Analysis]
6 Qumseya BJ, Wang H, Badie N, Uzomba RN, Parasa S, White DL, Wolfsen H, Sharma P, Wallace MB. Advanced imaging technologies increase detection of dysplasia and neoplasia in patients with Barrett's esophagus: a meta-analysis and systematic review. Clin Gastroenterol Hepatol 2013;11:1562-70.e1-2. [PMID: 23851020 DOI: 10.1016/j.cgh.2013.06.017] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 13.2] [Reference Citation Analysis]
7 Li X, Galipeau PC, Sanchez CA, Blount PL, Maley CC, Arnaudo J, Peiffer DA, Pokholok D, Gunderson KL, Reid BJ. Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression. Cancer Prev Res (Phila) 2008;1:413-23. [PMID: 19138988 DOI: 10.1158/1940-6207.CAPR-08-0121] [Cited by in Crossref: 52] [Cited by in F6Publishing: 31] [Article Influence: 4.0] [Reference Citation Analysis]
8 Gao S, Li S, Duan X, Gu Z, Ma Z, Yuan X, Feng X, Wang H. Inhibition of glycogen synthase kinase 3 beta (GSK3β) suppresses the progression of esophageal squamous cell carcinoma by modifying STAT3 activity. Mol Carcinog 2017;56:2301-16. [PMID: 28574599 DOI: 10.1002/mc.22685] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
9 Cook MB, Chow WH, Devesa SS. Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005. Br J Cancer. 2009;101:855-859. [PMID: 19672254 DOI: 10.1038/sj.bjc.6605246] [Cited by in Crossref: 234] [Cited by in F6Publishing: 336] [Article Influence: 18.0] [Reference Citation Analysis]
10 Lima VP, Lima MAP, André AR, Ferreira MVP, Barros MAP, Rabenhorst SHB. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: Correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. World J Gastroenterol 2008; 14(6): 884-891 [PMID: 18240345 DOI: 10.3748/wjg.14.884] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
11 Wang A, Mattek NC, Corless CL, Lieberman DA, Eisen GM. The value of traditional upper endoscopy as a diagnostic test for Barrett's esophagus. Gastrointest Endosc 2008;68:859-66. [PMID: 18514655 DOI: 10.1016/j.gie.2008.02.064] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zhang G, Li J, Li S, Wang Y. Exploring Spatial Trends and Influencing Factors for Gastric Cancer Based on Bayesian Statistics: A Case Study of Shanxi, China. Int J Environ Res Public Health 2018;15:E1824. [PMID: 30142954 DOI: 10.3390/ijerph15091824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Hu Z, Zhang M, Wang Z, Song J, Jiang W, Li L, Hu X. An observational study on the clinical features of esophageal cancer followed by multiple primary cancers. Future Oncol 2019;15:601-10. [PMID: 30477336 DOI: 10.2217/fon-2018-0621] [Reference Citation Analysis]
14 Yue C, Peng R, Wei W, Zhou B, Wen X, Gu R, Ming X, Li G, Chen H. Comparison on the Efficacy of Double Tract Gastric Interposition Reconstruction Versus Jejunal Interposition Reconstruction After Proximal Gastrectomy. Med Sci Monit 2020;26:e922504. [PMID: 32624566 DOI: 10.12659/MSM.922504] [Reference Citation Analysis]
15 Zhang X, Li C, Cao W, Zhang Z. Alterations of Gastric Microbiota in Gastric Cancer and Precancerous Stages. Front Cell Infect Microbiol 2021;11:559148. [PMID: 33747975 DOI: 10.3389/fcimb.2021.559148] [Reference Citation Analysis]
16 Liu G, Xu M, Gao T, Xu L, Zeng P, Bo H, Li F, Zhang W, Wang Z. Surgical Compliance and Outcomes in Gastric Cancer: a population-based cohort study. J Cancer 2019;10:779-88. [PMID: 30854083 DOI: 10.7150/jca.29073] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
17 Chen T, Yan F, Qian J, Guo M, Zhang H, Tang X, Chen F, Stoner GD, Wang X. Randomized phase II trial of lyophilized strawberries in patients with dysplastic precancerous lesions of the esophagus. Cancer Prev Res (Phila). 2012;5:41-50. [PMID: 22135048 DOI: 10.1158/1940-6207.capr-11-0469] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
18 Fouad YM, Mostafa I, Yehia R, El-Khayat H. Biomarkers of Barrett's esophagus. World J Gastrointest Pathophysiol 2014; 5(4): 450-456 [PMID: 25400988 DOI: 10.4291/wjgp.v5.i4.450] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
19 Cavatorta O, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G, Meschi T, De' Angelis GL, Di Mario F. Epidemiology of gastric cancer and risk factors. Acta Biomed 2018;89:82-7. [PMID: 30561423 DOI: 10.23750/abm.v89i8-S.7966] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
20 Guo J, Yu X, Gu J, Lin Z, Zhao G, Xu F, Lu C, Ge D. Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer. Tumour Biol 2016;37:6371-8. [PMID: 26631033 DOI: 10.1007/s13277-015-4504-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
21 Brown LM, Check DP, Devesa SS. Oral cavity and pharynx cancer incidence trends by subsite in the United States: changing gender patterns. J Oncol 2012;2012:649498. [PMID: 22577381 DOI: 10.1155/2012/649498] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
22 Feng H, Zheng J, Zheng C, Deng Z, Liao Q, Wang J, Li Y. The probability of Lymph node metastasis with a tumor size larger than and smaller than 4 cm is different in stages T1-T3 of Siewert type II adenocarcinoma of esophagogastric junction: A Population-Based Study. J Cancer 2021;12:6873-82. [PMID: 34659575 DOI: 10.7150/jca.63392] [Reference Citation Analysis]
23 Gao Y, Hu N, Han XY, Ding T, Giffen C, Goldstein AM, Taylor PR. Risk factors for esophageal and gastric cancers in Shanxi Province, China: a case-control study. Cancer Epidemiol. 2011;35:e91-e99. [PMID: 21846596 DOI: 10.1016/j.canep.2011.06.006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 80] [Article Influence: 7.5] [Reference Citation Analysis]
24 Sang Y, Gu H, Chen Y, Shi Y, Liu C, Lv L, Sun Y, Zhang Y. Long non-coding RNA CASC8 polymorphisms are associated with the risk of esophageal cancer in a Chinese population. Thorac Cancer 2020;11:2852-7. [PMID: 32875717 DOI: 10.1111/1759-7714.13612] [Reference Citation Analysis]
25 Johnson EA, De Lee R, Agni R, Pfau P, Reichelderfer M, Gopal DV. Probe-Based Confocal Laser Endomicroscopy to Guide Real-Time Endoscopic Therapy in Barrett's Esophagus with Dysplasia. Case Rep Gastroenterol. 2012;6:285-292. [PMID: 22754488 DOI: 10.1159/000338835] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
26 Goff LW, Thakkar N, Du L, Chan E, Tan BR, Cardin DB, McLeod HL, Berlin JD, Zehnbauer B, Fournier C, Picus J, Wang-Gillam A, Lee W, Lockhart AC. Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers. PLoS One 2014;9:e107424. [PMID: 25232828 DOI: 10.1371/journal.pone.0107424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
27 Chang CL, Lao-Sirieix P, Save V, De La Cueva Mendez G, Laskey R, Fitzgerald RC. Retinoic acid-induced glandular differentiation of the oesophagus. Gut 2007;56:906-17. [PMID: 17185354 DOI: 10.1136/gut.2006.097915] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
28 Titi M, Overhiser A, Ulusarac O, Falk GW, Chak A, Wang K, Sharma P. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012;143:564-566.e1. [PMID: 22561053 DOI: 10.1053/j.gastro.2012.04.051] [Cited by in Crossref: 95] [Cited by in F6Publishing: 76] [Article Influence: 9.5] [Reference Citation Analysis]
29 Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18:1945-1952. [PMID: 19531677 DOI: 10.1158/1055-9965.epi-09-0250] [Cited by in Crossref: 120] [Cited by in F6Publishing: 66] [Article Influence: 9.2] [Reference Citation Analysis]
30 Rosa F, Alfieri S, Tortorelli AP, Fiorillo C, Costamagna G, Doglietto GB. Trends in clinical features, postoperative outcomes, and long-term survival for gastric cancer: a Western experience with 1,278 patients over 30 years. World J Surg Oncol. 2014;12:217. [PMID: 25030691 DOI: 10.1186/1477-7819-12-217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
31 Ek WE, Levine DM, D’Amato M, Pedersen NL, Magnusson PK, Bresso F, Onstad LE, Schmidt PT, Törnblom H, Nordenstedt H. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett’s esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013;105:1711-1718. [PMID: 24168968 DOI: 10.1093/jnci/djt303] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 7.9] [Reference Citation Analysis]
32 Jo Y. New Consensus on the Management of Barrett's Dysplasia and Early Stage Esophageal Adenocarcinoma: Limited Evidence, but Best Available Guidance (Gastroenterology 2012;143:336-346). J Neurogastroenterol Motil 2012;18:455-6. [PMID: 23106010 DOI: 10.5056/jnm.2012.18.4.455] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Wang S, Chen L, Chen D, Chao J, Shao Y, Tang K, Chen W. Effect of Marital Status on the Survival of Patients With Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Study. Cancer Control 2021;28:10732748211066309. [PMID: 34910613 DOI: 10.1177/10732748211066309] [Reference Citation Analysis]
34 Ju MR, Paul S, Polanco P, Augustine M, Mansour J, Wang S, Porembka MR. Underutilization of Palliative Care in Metastatic Foregut Cancer Patients Is Associated with Socioeconomic Disparities. J Gastrointest Surg 2021;25:1404-11. [PMID: 32671798 DOI: 10.1007/s11605-020-04742-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Shah SV, Chheda YP, Pillai SK, Shah SV. Total oesophagectomy for squamous cell carcinoma with or without standard two field node dissection - a prospective study. Indian J Surg Oncol 2013;4:336-40. [PMID: 24426753 DOI: 10.1007/s13193-013-0264-5] [Reference Citation Analysis]
36 Fernández-Esparrach G, Rodríguez-D'Jesús A. [Radiofrequency in the treatment of Barrett's esophagus]. Gastroenterol Hepatol 2011;34:35-40. [PMID: 21216043 DOI: 10.1016/j.gastrohep.2010.10.007] [Reference Citation Analysis]
37 Epplein M, Shu XO, Xiang YB, Chow WH, Yang G, Li HL, Ji BT, Cai H, Gao YT, Zheng W. Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai Women’s and Men’s Health studies. Am J Epidemiol. 2010;172:397-406. [PMID: 20647333 DOI: 10.1093/aje/kwq144] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
38 Bashash M, Shah A, Hislop G, Brooks-Wilson A, Le N, Bajdik C. Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999. Can J Gastroenterol 2008;22:143-8. [PMID: 18299732 DOI: 10.1155/2008/645107] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
39 de Souza Giusti ACB, de Oliveira Salvador PTC, dos Santos J, Meira KC, Camacho AR, Guimarães RM, Souza DL. Trends and predictions for gastric cancer mortality in Brazil. World J Gastroenterol 2016; 22(28): 6527-6538 [PMID: 27605887 DOI: 10.3748/wjg.v22.i28.6527] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
40 Zhang HZ, Jin GF, Shen HB. Epidemiologic differences in esophageal cancer between Asian and Western populations. Chin J Cancer. 2012;31:281-286. [PMID: 22507220 DOI: 10.5732/cjc.011.10390] [Cited by in Crossref: 129] [Cited by in F6Publishing: 129] [Article Influence: 12.9] [Reference Citation Analysis]
41 Reddy D, Wainberg ZA. Targeted therapies for metastatic esophagogastric cancer. Curr Treat Options Oncol 2011;12:46-60. [PMID: 21298375 DOI: 10.1007/s11864-011-0138-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
42 Drahos J, Wu M, Anderson WF, Trivers KF, King J, Rosenberg PS, Eheman C, Cook MB. Regional variations in esophageal cancer rates by census region in the United States, 1999-2008. PLoS One 2013;8:e67913. [PMID: 23861830 DOI: 10.1371/journal.pone.0067913] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
43 Liu CY, Wu MC, Chen F, Ter-Minassian M, Asomaning K, Zhai R, Wang Z, Su L, Heist RS, Kulke MH, Lin X, Liu G, Christiani DC. A Large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis 2010;31:1259-63. [PMID: 20453000 DOI: 10.1093/carcin/bgq092] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.4] [Reference Citation Analysis]
44 Xu X, Xu L, Gao F, Wang J, Ye J, Zhou M, Zhu Y, Tao L. Identification of a novel gene fusion (BMX-ARHGAP) in gastric cardia adenocarcinoma. Diagn Pathol 2014;9:218. [PMID: 25499959 DOI: 10.1186/s13000-014-0218-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
45 Tee LY, Sim L, Tan LF, Lum J, Seetharaman SK. GIST of the stomach masquerading as recurrent falls in an older adult: a case report and review. BMC Gastroenterol 2021;21:381. [PMID: 34663231 DOI: 10.1186/s12876-021-01964-6] [Reference Citation Analysis]
46 Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Manag Res. 2017;9:781-788. [PMID: 29255373 DOI: 10.2147/cmar.s150350] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 5.4] [Reference Citation Analysis]
47 Lichthardt S, Kerscher A, Dietz UA, Jurowich C, Kunzmann V, von Rahden BH, Germer CT, Wiegering A. Original article: role of adjuvant chemotherapy in a perioperative chemotherapy regimen for gastric cancer. BMC Cancer 2016;16:650. [PMID: 27538392 DOI: 10.1186/s12885-016-2708-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
48 Apfel T, Lopez R, Sanaka MR, Thota PN. Risk of progression of Barrett's esophagus in patients with cirrhosis. World J Gastroenterol 2017; 23(18): 3287-3294 [PMID: 28566888 DOI: 10.3748/wjg.v23.i18.3287] [Reference Citation Analysis]
49 Huang YK, Kang WM, Ma ZQ, Liu YQ, Zhou L, Yu JC. Body mass index, serum total cholesterol, and risk of gastric high-grade dysplasia: A case-control study among Chinese adults. Medicine (Baltimore) 2016;95:e4730. [PMID: 27583914 DOI: 10.1097/MD.0000000000004730] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
50 Qumseya B, Panossian AM, Rizk C, Cangemi D, Wolfsen C, Raimondo M, Woodward T, Wallace MB, Wolfsen H. Predictors of esophageal stricture formation post endoscopic mucosal resection. Clin Endosc 2014;47:155-61. [PMID: 24765598 DOI: 10.5946/ce.2014.47.2.155] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
51 Reid BJ. Early events during neoplastic progression in Barrett's esophagus. Cancer Biomark 2010;9:307-24. [PMID: 22112482 DOI: 10.3233/CBM-2011-0162] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
52 Sun L, Subar AF, Bosire C, Dawsey SM, Kahle LL, Zimmerman TP, Abnet CC, Heller R, Graubard BI, Cook MB, Petrick JL. Dietary Flavonoid Intake Reduces the Risk of Head and Neck but Not Esophageal or Gastric Cancer in US Men and Women. J Nutr 2017;147:1729-38. [PMID: 28724656 DOI: 10.3945/jn.117.251579] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
53 Weledji EP, Enow Orock G, Ngowe MN. Intestinal metaplasia and anastomotic recurrence of gastric carcinoma. J Gastrointest Oncol 2014;5:474-80. [PMID: 25436128 DOI: 10.3978/j.issn.2078-6891.2014.048] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Piazuelo MB, Epplein M, Correa P. Gastric cancer: an infectious disease. Infect Dis Clin North Am. 2010;24:853-869, vii. [PMID: 20937454 DOI: 10.1016/j.idc.2010.07.010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
55 Epplein M, Nomura AM, Wilkens LR, Henderson BE, Kolonel LN. Nonsteroidal antiinflammatory drugs and risk of gastric adenocarcinoma: the multiethnic cohort study. Am J Epidemiol. 2009;170:507-514. [PMID: 19584132 DOI: 10.1093/aje/kwp162] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
56 Ahmadi A, Draganov P. Endoscopic mucosal resection in the upper gastrointestinal tract. World J Gastroenterol 2008; 14(13): 1984-1989 [PMID: 18395896 DOI: 10.3748/wjg.14.1984] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
57 Crane SJ, Locke GR 3rd, Harmsen WS, Zinsmeister AR, Romero Y, Talley NJ. Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study. Mayo Clin Proc 2008;83:1087-94. [PMID: 18828967 DOI: 10.4065/83.10.1087] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
58 Lin J, Su H, Zhou Q, Pan J, Zhou L. Predictive value of nomogram based on Kyoto classification of gastritis to diagnosis of gastric cancer. Scand J Gastroenterol 2022;:1-7. [PMID: 34994675 DOI: 10.1080/00365521.2021.2023626] [Reference Citation Analysis]
59 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12:354-362. [PMID: 16489633 DOI: 10.5732/cjc.011.10122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
60 Colquhoun A, Hannah H, Corriveau A, Hanley B, Yuan Y, Goodman KJ; CANHelp Working Group. Gastric Cancer in Northern Canadian Populations: A Focus on Cardia and Non-Cardia Subsites. Cancers (Basel) 2019;11:E534. [PMID: 30991639 DOI: 10.3390/cancers11040534] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
61 Saze Z, Kase K, Nakano H, Yamauchi N, Kaneta A, Watanabe Y, Hanayama H, Hayase S, Momma T, Kono K. Functional benefits of the double flap technique after proximal gastrectomy for gastric cancer. BMC Surg 2021;21:392. [PMID: 34740344 DOI: 10.1186/s12893-021-01390-1] [Reference Citation Analysis]
62 O'Doherty MG, Freedman ND, Hollenbeck AR, Schatzkin A, Murray LJ, Cantwell MM, Abnet CC. Association of dietary fat intakes with risk of esophageal and gastric cancer in the NIH-AARP diet and health study. Int J Cancer 2012;131:1376-87. [PMID: 22116732 DOI: 10.1002/ijc.27366] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
63 Lin MQ, Li YP, Wu SG, Sun JY, Lin HX, Zhang SY, He ZY. Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database. Onco Targets Ther 2016;9:6435-44. [PMID: 27799791 DOI: 10.2147/OTT.S112038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
64 Meves V, Behrens A, Pohl J. Diagnostics and Early Diagnosis of Esophageal Cancer. Viszeralmedizin 2015;31:315-8. [PMID: 26989385 DOI: 10.1159/000439473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
65 Lin X, Peng L, Xu X, Chen Y, Zhang Y, Huo X. Connecting gastrointestinal cancer risk to cadmium and lead exposure in the Chaoshan population of Southeast China. Environ Sci Pollut Res Int 2018;25:17611-9. [PMID: 29667054 DOI: 10.1007/s11356-018-1914-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
66 Rezaei-Tavirani M, Rezaei-Taviran S, Mansouri M, Rostami-Nejad M, Rezaei-Tavirani M. Protein-Protein Interaction Network Analysis for a Biomarker Panel Related to Human Esophageal Adenocarcinoma. Asian Pac J Cancer Prev 2017;18:3357-63. [PMID: 29286604 DOI: 10.22034/APJCP.2017.18.12.3357] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
67 Liu F, Zhou R, Jiang F, Liu G, Li K, Zhu G. Proposal of a Nomogram for Predicting Survival in Patients with Siewert Type II Adenocarcinoma of the Esophagogastric Junction After Preoperative Radiation. Ann Surg Oncol 2019;26:1292-300. [PMID: 30805805 DOI: 10.1245/s10434-019-07237-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
68 Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, Merat S, Pourshams A, Marjani HA, Ebadati A. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17:3062-3068. [PMID: 18990747 DOI: 10.1158/1055-9965.epi-08-0558] [Cited by in Crossref: 94] [Cited by in F6Publishing: 54] [Article Influence: 7.2] [Reference Citation Analysis]
69 Dolak W, Mesteri I, Asari R, Preusser M, Tribl B, Wrba F, Schoppmann SF, Hejna M, Trauner M, Häfner M, Püspök A. A pilot study of the endomicroscopic assessment of tumor extension in Barrett's esophagus-associated neoplasia before endoscopic resection. Endosc Int Open 2015;3:E19-28. [PMID: 26134766 DOI: 10.1055/s-0034-1377935] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
70 Ferrari F, Reis MAM. Study of risk factors for gastric cancer by populational databases analysis. World J Gastroenterol 2013; 19(48): 9383-9391 [PMID: 24409066 DOI: 10.3748/wjg.v19.i48.9383] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
71 Kraly JR, Jones MR, Gomez DG, Dickerson JA, Harwood MM, Eggertson M, Paulson TG, Sanchez CA, Odze R, Feng Z, Reid BJ, Dovichi NJ. Reproducible two-dimensional capillary electrophoresis analysis of Barrett's esophagus tissues. Anal Chem 2006;78:5977-86. [PMID: 16944874 DOI: 10.1021/ac061029+] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
72 Ashktorab H, Nouri Z, Nouraie M, Razjouyan H, Lee EE, Dowlati E, El-Seyed el-W, Laiyemo A, Brim H, Smoot DT. Esophageal carcinoma in African Americans: a five-decade experience. Dig Dis Sci 2011;56:3577-82. [PMID: 21847566 DOI: 10.1007/s10620-011-1853-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
73 Paulson TG, Maley CC, Li X, Li H, Sanchez CA, Chao DL, Odze RD, Vaughan TL, Blount PL, Reid BJ. Chromosomal instability and copy number alterations in Barrett’s esophagus and esophageal adenocarcinoma. Clin Cancer Res. 2009;15:3305-3314. [PMID: 19417022 DOI: 10.1158/1078-0432.ccr-08-2494] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 5.8] [Reference Citation Analysis]
74 Aho JM, Nenadic IZ, Aristizabal S, Wigle DA, Tschumperlin DJ, Urban MW. Use of Shear Wave Ultrasound Vibrometry for Detection of Simulated Esophageal Malignancy in Ex Vivo Porcine Esophagi. Biomed Phys Eng Express 2016;2:065002. [PMID: 28948043 DOI: 10.1088/2057-1976/2/6/065002] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Zhao J, Zhao J, Du F, Zhang Y, Shen G, Zhu H, Ji F, Ma F, Dong L, Kan J, Zheng F, Chen H, Wang Z, Xu B. Cardia and Non-Cardia Gastric Cancer Have Similar Stage-for-Stage Prognoses After R0 Resection: a Large-Scale, Multicenter Study in China. J Gastrointest Surg 2016;20:700-7. [PMID: 26831062 DOI: 10.1007/s11605-016-3089-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
76 Galipeau PC, Li X, Blount PL, Maley CC, Sanchez CA, Odze RD, Ayub K, Rabinovitch PS, Vaughan TL, Reid BJ. NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma. PLoS Med. 2007;4:e67. [PMID: 17326708 DOI: 10.1371/journal.pmed.0040067] [Cited by in Crossref: 190] [Cited by in F6Publishing: 168] [Article Influence: 12.7] [Reference Citation Analysis]
77 Li JW, Tan MT, Ang TL, Teo EK. Chemoprevention trials of GI cancers in Asia. Best Pract Res Clin Gastroenterol 2015;29:967-78. [PMID: 26651257 DOI: 10.1016/j.bpg.2015.09.014] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
78 Fischbach LA, Graham DY, Kramer JR, Rugge M, Verstovsek G, Parente P, Alsarraj A, Fitzgerald S, Shaib Y, Abraham NS, Kolpachi A, Gupta S, Vela MF, Velez M, Cole R, Anand B, El Serag HB. Association between Helicobacter pylori and Barrett's esophagus: a case-control study. The American journal of gastroenterology. 2014;109:357-368. [PMID: 24419485 DOI: 10.1038/ajg.2013.443] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 5.4] [Reference Citation Analysis]
79 Khattak MA, Martin HL, Karapetis CS. Targeted therapy for esophagogastric cancers: a review. Onco Targets Ther 2012;5:91-102. [PMID: 22719211 DOI: 10.2147/OTT.S25117] [Reference Citation Analysis]
80 Wu SG, Zhang WW, Sun JY, Li FY, Lin Q, He ZY. Patterns of Distant Metastasis Between Histological Types in Esophageal Cancer. Front Oncol 2018;8:302. [PMID: 30135855 DOI: 10.3389/fonc.2018.00302] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
81 Goldfarb M, Brower S, Schwaitzberg SD. Minimally invasive surgery and cancer: controversies part 1. Surg Endosc. 2010;24:304-334. [PMID: 19572178 DOI: 10.1007/s00464-009-0583-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 1.9] [Reference Citation Analysis]
82 Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: a meta-analysis. Cancer Prev Res (Phila). 2008;1:329-338. [PMID: 19138977 DOI: 10.1158/1940-6207.capr-08-0109] [Cited by in Crossref: 220] [Cited by in F6Publishing: 116] [Article Influence: 16.9] [Reference Citation Analysis]
83 Hashemian M, Murphy G, Etemadi A, Dawsey SM, Liao LM, Abnet CC. Nut and peanut butter consumption and the risk of esophageal and gastric cancer subtypes. Am J Clin Nutr 2017;106:858-64. [PMID: 28768652 DOI: 10.3945/ajcn.117.159467] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
84 Alvarez H, Rojas PL, Yong KT, Ding H, Xu G, Prasad PN, Wang J, Canto M, Eshleman JR, Montgomery EA, Maitra A. Mesothelin is a specific biomarker of invasive cancer in the Barrett-associated adenocarcinoma progression model: translational implications for diagnosis and therapy. Nanomedicine 2008;4:295-301. [PMID: 18691948 DOI: 10.1016/j.nano.2008.06.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
85 Yamashita K, Sakuramoto S, Nemoto M, Shibata T, Mieno H, Katada N, Kikuchi S, Watanabe M. Trend in gastric cancer: 35 years of surgical experience in Japan. World J Gastroenterol 2011; 17(29): 3390-3397 [PMID: 21876631 DOI: 10.3748/wjg.v17.i29.3390] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
86 Paulson TG, Galipeau PC, Xu L, Kissel HD, Li X, Blount PL, Sanchez CA, Odze RD, Reid BJ. p16 mutation spectrum in the premalignant condition Barrett's esophagus. PLoS One 2008;3:e3809. [PMID: 19043591 DOI: 10.1371/journal.pone.0003809] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
87 Epplein M, Shu XO, Xiang YB, Chow WH, Yang G, Li HL, Ji BT, Cai H, Gao YT, Zheng W. Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai Women's and Men's Health studies. Am J Epidemiol. 2010;172:397-406. [PMID: 20647333 DOI: 10.1093/aje/kwg144] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
88 Haile RW, John EM, Levine AJ, Cortessis VK, Unger JB, Gonzales M, Ziv E, Thompson P, Spruijt-Metz D, Tucker KL, Bernstein JL, Rohan TE, Ho GY, Bondy ML, Martinez ME, Cook L, Stern MC, Correa MC, Wright J, Schwartz SJ, Baezconde-Garbanati L, Blinder V, Miranda P, Hayes R, Friedman-Jiménez G, Monroe KR, Haiman CA, Henderson BE, Thomas DC, Boffetta P. A review of cancer in U.S. Hispanic populations. Cancer Prev Res (Phila) 2012;5:150-63. [PMID: 22307564 DOI: 10.1158/1940-6207.CAPR-11-0447] [Cited by in Crossref: 66] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
89 Kim JJ. Upper gastrointestinal cancer and reflux disease. J Gastric Cancer 2013;13:79-85. [PMID: 23844321 DOI: 10.5230/jgc.2013.13.2.79] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
90 Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010;102:1344-1353. [PMID: 20716718 DOI: 10.1093/jnci/djq289] [Cited by in Crossref: 179] [Cited by in F6Publishing: 161] [Article Influence: 14.9] [Reference Citation Analysis]
91 Wong HH, Chu P. Immunohistochemical features of the gastrointestinal tract tumors. J Gastrointest Oncol 2012;3:262-84. [PMID: 22943017 DOI: 10.3978/j.issn.2078-6891.2012.019] [Cited by in F6Publishing: 31] [Reference Citation Analysis]
92 Yao Y, Shi J, Zhang Z, Zhang F, Ma R, Zhao Y. The radiation-sensitizing effect of flavopiridol in the esophageal cancer cell line Eca109. Oncol Lett 2013;5:1872-6. [PMID: 23833659 DOI: 10.3892/ol.2013.1291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
93 Burge ME, Smith D, Topham C, Jackson DP, Anthoney DA, Halstead F, Seymour MT. A phase I and II study of 2-weekly irinotecan with capecitabine in advanced gastroesophageal adenocarcinoma. Br J Cancer 2006;94:1281-6. [PMID: 16622464 DOI: 10.1038/sj.bjc.6603084] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
94 Mathieu LN, Kanarek NF, Tsai HL, Rudin CM, Brock MV. Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008). Dis Esophagus. 2014;27:757-763. [PMID: 24118313 DOI: 10.1111/dote.12147] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 5.2] [Reference Citation Analysis]
95 O'Doherty MG, Abnet CC, Murray LJ, Woodside JV, Anderson LA, Brockman JD, Cantwell MM. Iron intake and markers of iron status and risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Causes Control 2010;21:2269-79. [PMID: 20936528 DOI: 10.1007/s10552-010-9652-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
96 Tian D, Mo SJ, Han LK, Cheng L, Huang H, Hao S, Guan YL, Jiang KY, Deng JY, Feng HH, Wen HY, Fu MY. Investigation of Dietary Factors and Esophageal Cancer Knowledge: Comparison of Rural Residents in High- and Low-incidence Areas. Sci Rep. 2018;8:4914. [PMID: 29559669 DOI: 10.1038/s41598-018-23251-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
97 Chou SH, Tung YC, Wu LS, Chang CJ, Kung S, Chu PH. Severity of chronic periodontitis and risk of gastrointestinal cancers: A population-based follow-up study from Taiwan. Medicine (Baltimore) 2018;97:e11386. [PMID: 29979428 DOI: 10.1097/MD.0000000000011386] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
98 Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RD. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005;9:718-725. [PMID: 15862270 DOI: 10.1016/j.gassur.2004.12.002] [Cited by in Crossref: 93] [Cited by in F6Publishing: 91] [Article Influence: 5.5] [Reference Citation Analysis]
99 Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-713. [PMID: 24618998 DOI: 10.1158/1055-9965].] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
100 Mokrowiecka A, Zonnur S, Veits L, Musial J, Kordek R, Lochowski M, Kozak J, Malecka-Panas E, Vieth M, Hartmann A. Liver-intestine-cadherin is a sensitive marker of intestinal differentiation during Barrett's carcinogenesis. Dig Dis Sci 2013;58:699-705. [PMID: 23053896 DOI: 10.1007/s10620-012-2425-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
101 Garcia JM, Splenser AE, Kramer J, Alsarraj A, Fitzgerald S, Ramsey D, El-Serag HB. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett’s esophagus: a case-control study. Clin Gastroenterol Hepatol. 2014;12:229-238.e3. [PMID: 23954649 DOI: 10.1016/j.cgh.2013.07.038] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
102 Spechler SJ. Managing Barrett's oesophagus. BMJ 2003;326:892-4. [PMID: 12714452 DOI: 10.1136/bmj.326.7395.892] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
103 Pan L, Liu X, Wang W, Zhu L, Yu W, Lv W, Hu J. The Influence of Different Treatment Strategies on the Long-Term Prognosis of T1 Stage Esophageal Cancer Patients. Front Oncol 2021;11:700088. [PMID: 34722247 DOI: 10.3389/fonc.2021.700088] [Reference Citation Analysis]
104 Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23:700-713. [PMID: 24618998 DOI: 10.1158/1055-9965.epi-13-1057] [Cited by in Crossref: 681] [Cited by in F6Publishing: 477] [Article Influence: 85.1] [Reference Citation Analysis]
105 He Z, Wu S, Li Q, Lin Q, Xu J. Use of the metastatic lymph node ratio to evaluate the prognosis of esophageal cancer patients with node metastasis following radical esophagectomy. PLoS One. 2013;8:e73446. [PMID: 24039944 DOI: 10.1371/journal.pone.0073446] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
106 Jiang D, He Z, Wang C, Zhou Y, Li F, Pu W, Zhang X, Feng X, Zhang M, Yecheng X, Xu Y, Jin L, Guo S, Wang J, Wang M. Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma. Cell Death Dis 2018;10:1. [PMID: 30578410 DOI: 10.1038/s41419-018-1236-z] [Cited by in Crossref: 104] [Cited by in F6Publishing: 47] [Article Influence: 26.0] [Reference Citation Analysis]
107 Ding P, Gao Z, Zheng C, Chen J, Li K, Gao S. Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study. BMC Cancer 2019;19:905. [PMID: 31510966 DOI: 10.1186/s12885-019-6112-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
108 Lee JK, Enns R. Endoscopic mucosal resection in the setting of Barrett's esophagus. Can J Gastroenterol 2007;21:151-4. [PMID: 17377642 DOI: 10.1155/2007/198728] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
109 Oh SC, Sur HY, Sung HJ, Choi IK, Park SS, Seo JH, Jeen YT, Chun HJ, Shin SW, Mok YJ, Kim JS, Kim YH. A phase II study of biweekly dose-intensified oral capecitabine plus irinotecan (bXELIRI) for patients with advanced or metastatic gastric cancer. Br J Cancer 2007;96:1514-9. [PMID: 17473829 DOI: 10.1038/sj.bjc.6603752] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
110 Haas M, Dimmler A, Hohenberger W, Grabenbauer GG, Niedobitek G, Distel LV. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. BMC Gastroenterol. 2009;9:65. [PMID: 19732435 DOI: 10.1186/1471-230x-9-65] [Cited by in Crossref: 99] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
111 Pauli EM, Schomisch SJ, Furlan JP, Marks AS, Chak A, Lash RH, Ponsky JL, Marks JM. Biodegradable esophageal stent placement does not prevent high-grade stricture formation after circumferential mucosal resection in a porcine model. Surg Endosc. 2012;26:3500-3508. [PMID: 22684976 DOI: 10.1007/s00464-012-2373-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
112 Shi N, Jin F, Zhang X, Clinton SK, Pan Z, Chen T. Overexpression of human β-defensin 2 promotes growth and invasion during esophageal carcinogenesis. Oncotarget 2014;5:11333-44. [PMID: 25226614 DOI: 10.18632/oncotarget.2416] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
113 Zakko L, Lutzke L, Wang KK. Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am 2017;26:163-78. [PMID: 28279462 DOI: 10.1016/j.soc.2016.10.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
114 Zhang H, Sun LL, Meng YL, Song GY, Hu JJ, Lu P, Ji B. Survival trends in gastric cancer patients of Northeast China. World J Gastroenterol 2011; 17(27): 3257-3262 [PMID: 21912476 DOI: 10.3748/wjg.v17.i27.3257] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
115 O’Doherty MG, Cantwell MM, Murray LJ, Anderson LA, Abnet CC. Dietary fat and meat intakes and risk of reflux esophagitis, Barrett’s esophagus and esophageal adenocarcinoma. Int J Cancer. 2011;129:1493-1502. [PMID: 21455992 DOI: 10.1002/ijc.26108] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 5.1] [Reference Citation Analysis]
116 Zhao L, Huang H, Zhao D, Wang C, Tian Y, Yuan X, Ma F, Ren H, Zhao Y, Aimaiti S, Zhang S, Zhou H, Wang T, Wang N, Sun Y, Bai X, Chen Y. Clinicopathological Characteristics and Prognosis of Proximal and Distal Gastric Cancer during 1997-2017 in China National Cancer Center. J Oncol 2019;2019:9784039. [PMID: 31312217 DOI: 10.1155/2019/9784039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
117 Sato S, Fushimi S, Tahata Y, Mizutamari H, Mimori N, Kato Y, Horikawa Y. Feasibility of Endoscopic Screening for Upper Gastrointestinal Malignancy in a Comprehensive Health Checkup. Intern Med 2021;60:1493-9. [PMID: 33328405 DOI: 10.2169/internalmedicine.6020-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
118 Bibby BAS, Miranda CS, Reynolds JV, Cawthorne CJ, Maher SG. Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma. BMC Cancer 2019;19:784. [PMID: 31391080 DOI: 10.1186/s12885-019-5996-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
119 Nomura AM, Wilkens LR, Henderson BE, Epplein M, Kolonel LN. The association of cigarette smoking with gastric cancer: the multiethnic cohort study. Cancer Causes Control 2012;23:51-8. [PMID: 22037905 DOI: 10.1007/s10552-011-9854-0] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
120 Tomita N, Abdollahi B, Wei J, Ren B, Suriawinata A, Hassanpour S. Attention-Based Deep Neural Networks for Detection of Cancerous and Precancerous Esophagus Tissue on Histopathological Slides. JAMA Netw Open. 2019;2:e1914645. [PMID: 31693124 DOI: 10.1001/jamanetworkopen.2019.14645] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 12.3] [Reference Citation Analysis]
121 Thompson OM, Beresford SA, Kirk EA, Bronner MP, Vaughan TL. Serum leptin and adiponectin levels and risk of Barrett’s esophagus and intestinal metaplasia of the gastroesophageal junction. Obesity (Silver Spring). 2010;18:2204-2211. [PMID: 20111023 DOI: 10.1038/oby.2009.508] [Cited by in Crossref: 46] [Cited by in F6Publishing: 45] [Article Influence: 3.8] [Reference Citation Analysis]
122 Wideroff L, Vaughan TL, Farin FM, Gammon MD, Risch H, Stanford JL, Chow WH. GST, NAT1, CYP1A1 polymorphisms and risk of esophageal and gastric adenocarcinomas. Cancer Detect Prev. 2007;31:233-236. [PMID: 17646057 DOI: 10.1016/j.cdp.2007.03.004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
123 Kaz AM, Grady WM, Stachler MD, Bass AJ. Genetic and Epigenetic Alterations in Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am 2015;44:473-89. [PMID: 26021206 DOI: 10.1016/j.gtc.2015.02.015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.9] [Reference Citation Analysis]
124 Zhao P, Xiao SM, Tang LC, Ding Z, Zhou X, Chen XD. Proximal gastrectomy with jejunal interposition and TGRY anastomosis for proximal gastric cancer. World J Gastroenterol 2014; 20(25): 8268-8273 [PMID: 25009402 DOI: 10.3748/wjg.v20.i25.8268] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
125 R P, N P, J T. Expression of Matrix Metalloproteinase-9 in Gastric Cancer. Cureus 2021;13:e18195. [PMID: 34707964 DOI: 10.7759/cureus.18195] [Reference Citation Analysis]
126 Wu HD, Zhang JJ, Zhou BJ. The effect of metformin on esophageal cancer risk in patients with type 2 diabetes mellitus: a systematic review and meta‑analysis. Clin Transl Oncol 2021;23:275-82. [PMID: 32507907 DOI: 10.1007/s12094-020-02415-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
127 Hao Y, Sood S, Triadafilopoulos G, Kim JH, Wang Z, Sahbaie P, Omary MB, Lowe AW. Gene expression changes associated with Barrett's esophagus and Barrett's-associated adenocarcinoma cell lines after acid or bile salt exposure. BMC Gastroenterol 2007;7:24. [PMID: 17597535 DOI: 10.1186/1471-230X-7-24] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
128 Schulpen M, Peeters PH, van den Brandt PA. Mediterranean diet adherence and risk of esophageal and gastric cancer subtypes in the Netherlands Cohort Study. Gastric Cancer 2019;22:663-74. [PMID: 30771119 DOI: 10.1007/s10120-019-00927-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
129 Le Bras GF, Farooq MH, Falk GW, Andl CD. Esophageal cancer: The latest on chemoprevention and state of the art therapies. Pharmacol Res 2016;113:236-44. [PMID: 27565381 DOI: 10.1016/j.phrs.2016.08.021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
130 Ji FX, Zhao JD, Shen GS, Cao CZ, He JX, Ma XF, Wang LJ, Li JZ, Geng PL. Morbidity features among Tibet, Hui and Han nationalities with gastric cancer: an analysis of 1165 cases. Shijie Huaren Xiaohua Zazhi 2009; 17(19): 1993-1995 [DOI: 10.11569/wcjd.v17.i19.1993] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
131 Aragonés N, Ramis R, Pollán M, Pérez-Gómez B, Gómez-Barroso D, Lope V, Boldo EI, García-Pérez J, López-Abente G. Oesophageal cancer mortality in Spain: a spatial analysis. BMC Cancer 2007;7:3. [PMID: 17201909 DOI: 10.1186/1471-2407-7-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
132 Yang SJ, Wang HY, Li XQ, Du HZ, Zheng CJ, Chen HG, Mu XY, Yang CX. Genetic polymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China. World J Gastroenterol 2007; 13(43): 5760-5764 [PMID: 17963305 DOI: 10.3748/wjg.v13.i43.5760] [Cited by in CrossRef: 58] [Cited by in F6Publishing: 59] [Article Influence: 3.9] [Reference Citation Analysis]
133 Lu JB, Sun XB, Dai DX, Zhu SK, Chang QL, Liu SZ, Duan WJ. Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol 2003; 9(11): 2400-2403 [PMID: 14606064 DOI: 10.3748/wjg.v9.i11.2400] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
134 Peng F, Hu D, Lin X, Chen G, Liang B, Zhang H, Dong X, Lin J, Zheng X, Niu W. Analysis of Preoperative Metabolic Risk Factors Affecting the Prognosis of Patients with Esophageal Squamous Cell Carcinoma: The Fujian Prospective Investigation of Cancer (FIESTA) Study. EBioMedicine 2017;16:115-23. [PMID: 28163045 DOI: 10.1016/j.ebiom.2017.01.035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
135 Jemal A, Ward E, Thun M. Declining death rates reflect progress against cancer. PLoS One 2010;5:e9584. [PMID: 20231893 DOI: 10.1371/journal.pone.0009584] [Cited by in Crossref: 149] [Cited by in F6Publishing: 135] [Article Influence: 12.4] [Reference Citation Analysis]
136 Lam-Himlin DM, Daniels JA, Gayyed MF, Dong J, Maitra A, Pan D, Montgomery EA, Anders RA. The hippo pathway in human upper gastrointestinal dysplasia and carcinoma: a novel oncogenic pathway. Int J Gastrointest Cancer 2006;37:103-9. [PMID: 18175224 DOI: 10.1007/s12029-007-0010-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 37] [Article Influence: 0.4] [Reference Citation Analysis]
137 Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008;100:1184-1187. [PMID: 18695138 DOI: 10.1093/jnci/djn211] [Cited by in Crossref: 466] [Cited by in F6Publishing: 442] [Article Influence: 33.3] [Reference Citation Analysis]
138 Mullin JM, Valenzano MC, Trembeth S, Allegretti PD, Verrecchio JJ, Schmidt JD, Jain V, Meddings JB, Mercogliano G, Thornton JJ. Transepithelial leak in Barrett's esophagus. Dig Dis Sci. 2006;51:2326-2336. [PMID: 17103306 DOI: 10.1007/S10620-006-9478-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
139 Spechler SJ. Are we underestimating acid reflux? Gut 2004;53:162-3. [PMID: 14724142 DOI: 10.1136/gut.2003.025205] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
140 Chen WW, Wang F, Xu RH. Platinum-based versus non-platinum-based chemotherapy as first line treatment of inoperable, advanced gastric adenocarcinoma: a meta-analysis. PLoS One. 2013;8:e68974. [PMID: 23874831 DOI: 10.1371/journal.pone.0068974] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
141 Guo Q, Peng Y, Yang H, Guo J. Prognostic Nomogram for Postoperative Patients With Gastroesophageal Junction Cancer of No Distant Metastasis. Front Oncol 2021;11:643261. [PMID: 33937047 DOI: 10.3389/fonc.2021.643261] [Reference Citation Analysis]